Search results
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 15 hours agoReal-world study data suggest there is little difference among five drug classes commonly used to treat PsA in terms of their ability to improve both joint and skin symptoms.
Roger Goodell Throws His Own Network Under The Bus During ‘Sunday Ticket’ Testimony
Sports Illustrated· 1 day agoA group of "Sunday Ticket" subscribers filed an antitrust lawsuit against the NFL for selling the...
Infusions for psoriatic arthritis: Purpose, medications, benefits
Medical News Today· 7 days agoInfusion therapy for psoriatic arthritis (PsA) involves administering medications known as biologics...
NFL great JJ Watt reacts to TY Hilton's son commitment to Wisconsin: 'Happy to be rooting for a...
Fox News· 4 days agoFour-time NFL Pro Bowler T.Y. Hilton's Father's Day weekend got off to a memorable start. High...
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Increases By 156.6%
ETF DAILY NEWS· 6 days ago180 Life Sciences Corp. (NASDAQ:ATNF – Get Free Report) was the target of a significant growth in...
Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic...
Nature· 3 days agoDelivering bacteria-based drug for cancer therapy is limited by their penetration into extracellular matrix (ECM). Here the authors report effective depletion of ECM with hyperbaric oxygen therapeutic ...
Is 'Difficult-to-Treat' RA a Lost Cause?
MedPage Today· 7 days agoRheumatologists are still struggling with what to do when multiple state-of-the-art treatments have failed to bring rheumatoid arthritis (RA) under...
Analysts mixed on pluses, minuses of HanesBrands sale of Champion
Winston-Salem Journal· 3 days agoHanesBrands Inc.’s pending $1.2 billion to $1.5 billion sale of its iconic global Champion brand —...
Kairos Pharma, Ltd. Plans $6 Million IPO for Week of June 17th (KAPA)
ETF DAILY NEWS· 7 days agoKairos Pharma, Ltd. (KAPA) expects to raise $6 million in an initial public offering (IPO) on the...
Short Interest in UCB SA (OTCMKTS:UCBJY) Rises By 152.5%
ETF DAILY NEWS· 5 days agoUCB SA (OTCMKTS:UCBJY – Get Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 15,400 shares, a growth of 152.5% from ...